TruSpine Technologies PLC - medical device company - Says Evrensel Capital Partners Ltd, which committed to subscribe in September 2020 for 694,444 new shares in TruSpine at a price of 36p per shares, raising gross proceeds of GBP250,000, has not provided funds due to TruSpine and is therefore in default on its commitment. The company says it has passed the matter on to its legal advisers.
Current stock price: 7.30 pence
By Evelina Grecenko; evelinagrecenko@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.